Medtech company HighLife picks up Series B funding
Paris-based HighLife SAS, a medtech company, has raised 32 million euros in Series B funding. U.S. Venture Partners and Andera Partners led the round.
17 January 2019•1 min read
Paris-based HighLife SAS, a medtech company, has raised 32 million euros in Series B funding. U.S. Venture Partners and Andera Partners led the round.